Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Capital Expenditures (2019 - 2025)

Historic Capital Expenditures for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $175000.0.

  • Korro Bio's Capital Expenditures fell 9641.25% to $175000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 8958.3%. This contributed to the annual value of $17.9 million for FY2024, which is 12845.84% up from last year.
  • Per Korro Bio's latest filing, its Capital Expenditures stood at $175000.0 for Q3 2025, which was down 9641.25% from $140000.0 recorded in Q2 2025.
  • In the past 5 years, Korro Bio's Capital Expenditures registered a high of $6.0 million during Q2 2024, and its lowest value of -$16000.0 during Q3 2022.
  • For the 5-year period, Korro Bio's Capital Expenditures averaged around $1.8 million, with its median value being $750000.0 (2021).
  • Its Capital Expenditures has fluctuated over the past 5 years, first crashed by 10514.47% in 2022, then surged by 11045000.0% in 2023.
  • Over the past 5 years, Korro Bio's Capital Expenditures (Quarter) stood at $61000.0 in 2021, then soared by 8319.67% to $5.1 million in 2022, then crashed by 67.78% to $1.7 million in 2023, then dropped by 12.27% to $1.5 million in 2024, then tumbled by 87.95% to $175000.0 in 2025.
  • Its Capital Expenditures was $175000.0 in Q3 2025, compared to $140000.0 in Q2 2025 and $119000.0 in Q1 2025.